相似文献
1
Comparing Approaches to Measure Frailty in Medicare Data: Deficit-Accumulation Frailty Index Versus Phenotypic Frailty.
J Gerontol A Biol Sci Med Sci. 2018 Jun 14;73(7):989-990. doi: 10.1093/gerona/gly054.
2
Operationalizing Frailty Using the Frailty Phenotype and Deficit Accumulation Approaches.
Interdiscip Top Gerontol Geriatr. 2015;41:66-73. doi: 10.1159/000381164. Epub 2015 Jul 17.
3
Claims-Based Frailty Index Options.
J Gerontol A Biol Sci Med Sci. 2018 Jun 14;73(7):988. doi: 10.1093/gerona/gly055.
4
Frailty, Equity, and Medicare Costs.
Ann Intern Med. 2020 Apr 21;172(8):562-563. doi: 10.7326/M20-0873. Epub 2020 Apr 7.
5
Comparison and Clinical Applications of the Frailty Phenotype and Frailty Index Approaches.
Interdiscip Top Gerontol Geriatr. 2015;41:74-84. doi: 10.1159/000381166. Epub 2015 Jul 17.
6
External validation of the claims-based frailty index in the national health and aging trends study cohort.
Am J Epidemiol. 2017 Sep 15;186(6):745-747. doi: 10.1093/aje/kwx257.
7
Function and Frailty: Value Added in Medicare.
Ann Intern Med. 2023 Apr;176(4):578-579. doi: 10.7326/M23-0563. Epub 2023 Apr 4.
8
Comparing clinician descriptions of frailty and geriatric syndromes using electronic health records: a retrospective cohort study.
BMC Geriatr. 2017 Oct 25;17(1):248. doi: 10.1186/s12877-017-0645-7.
9
Frailty Before Critical Illness and Mortality for Elderly Medicare Beneficiaries.
J Am Geriatr Soc. 2015 Jun;63(6):1121-8. doi: 10.1111/jgs.13436.
10
Measuring Frailty in Medicare Data: Development and Validation of a Claims-Based Frailty Index.
J Gerontol A Biol Sci Med Sci. 2018 Jun 14;73(7):980-987. doi: 10.1093/gerona/glx229.
引用本文的文献
1
Trends in post-acute care and outcomes for Medicare beneficiaries hospitalized for heart failure between 2008 and 2015.
J Am Geriatr Soc. 2023 Mar;71(3):730-741. doi: 10.1111/jgs.18109. Epub 2022 Nov 1.
2
Heath status, frailty, and multimorbidity in patients with emergency general surgery conditions.
Surgery. 2022 Jul;172(1):446-452. doi: 10.1016/j.surg.2022.02.011. Epub 2022 Apr 6.
3
Association of Sodium-Glucose Cotransporter-2 Inhibitors With Fracture Risk in Older Adults With Type 2 Diabetes.
JAMA Netw Open. 2021 Oct 1;4(10):e2130762. doi: 10.1001/jamanetworkopen.2021.30762.
4
A roadmap to build a phenotypic metric of ageing: insights from the Baltimore Longitudinal Study of Aging.
J Intern Med. 2020 Apr;287(4):373-394. doi: 10.1111/joim.13024. Epub 2020 Feb 27.
5
The EMPagliflozin compaRative effectIveness and SafEty (EMPRISE) study programme: Design and exposure accrual for an evaluation of empagliflozin in routine clinical care.
Endocrinol Diabetes Metab. 2019 Nov 26;3(1):e00103. doi: 10.1002/edm2.103. eCollection 2020 Jan.
6
Using Real-World Data to Predict Findings of an Ongoing Phase IV Cardiovascular Outcome Trial: Cardiovascular Safety of Linagliptin Versus Glimepiride.
Diabetes Care. 2019 Dec;42(12):2204-2210. doi: 10.2337/dc19-0069. Epub 2019 Jun 25.
7
Validation of a Claims-Based Frailty Index Against Physical Performance and Adverse Health Outcomes in the Health and Retirement Study.
J Gerontol A Biol Sci Med Sci. 2019 Jul 12;74(8):1271-1276. doi: 10.1093/gerona/gly197.
本文引用的文献
1
Measuring Frailty in Medicare Data: Development and Validation of a Claims-Based Frailty Index.
J Gerontol A Biol Sci Med Sci. 2018 Jun 14;73(7):980-987. doi: 10.1093/gerona/glx229.
2
Development of a Claims-based Frailty Indicator Anchored to a Well-established Frailty Phenotype.
Med Care. 2017 Jul;55(7):716-722. doi: 10.1097/MLR.0000000000000729.
3
Measuring frailty using claims data for pharmacoepidemiologic studies of mortality in older adults: evidence and recommendations.
Pharmacoepidemiol Drug Saf. 2014 Sep;23(9):891-901. doi: 10.1002/pds.3674. Epub 2014 Jun 24.
Zotero 插件